WHITEFIELD'S OINTMENT

This brand name is authorized in Nigeria.

Active ingredients

The drug WHITEFIELD'S OINTMENT contains a combination of these active pharmaceutical ingredients (APIs):

1	Banzoic acid UNII 8SKN0B0MIM - BENZOIC ACID
	Read more about Banzoic acid
2	Salicylic acid UNII O414PZ4LPZ - SALICYLIC ACID
	Salicylic acid has bacteriostatic and fungicidal actions, but it is its keratolytic properties which are important for this medicinal product. When applied externally it produces slow and painless destruction of the epithelium.
	Read more about Salicylic acid

Packages

This drug has been approved in Nigeria as follows:

Identifier	Form	Presentation	Description	Approval
04-4598	Ointment	NINO WHITEFIELD OINTMENT OINTMENT 6%; 3% 800gm24,400gm30	35 RNW-PP-346809 NINO WHITEFIELD OINTMENT NINO WHITFIELD OINTMENT SALICYLIC ACID BENZOIC ACID Apr-98 Drugs Nigerian Products 800gm24,400gm30 OTC 8/2/2023 NINO PHARMACEUTICAL CHEMICAL AND COMPANY LIMITED, NINO CRESCENT,ERA VILLAGE,OJO LOCAL SURULERE LAGOS 8033479471 ninopharmaceuticals@yahoo.com NINO PHARMACEUTICALS & CHEMICAL CO. LTD, IJANIKIN OTO AWORI LCDA, BY FEDERAL GOVT. COLLEGE IJANINKIN, Nigeria	28/09/2023
C4-2056	Ointment	ZEENAT WHITEFIELD'S OINTMENT OINTMENT 6%; 3% 1 X 30G	4 ZEENAT WHITEFIELD'S OINTMENT ZEENAT BENZOIC ACID BP 6%W/W SALICYLIC ACID BP 3% W/W POM OINTMENT 1 X 30G ANTIBIOTIC ZEENAT PHARMACY LTD. GREEN HOUSE, PLOT 384, YASHANA ROAD, NAIBAWA QUARTERS, KANO STATE. CIRON DRUGS & PHARMA PVT. LTD. N-118, 119, M.I.D.C., TARAPUR BOISAR, DIST. THANE-401506, MAHARASHTRA, INDIA. GMP- CLEARANCE ;LR-NA; FEES-PAID;NP:NA 21/02/2019 C4-2056	23/02/2023

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
D01AE20	Combinations	D Dermatologicals → D01 Antifungals for dermatological use → D01A Antifungals for topical use → D01AE Other antifungals for topical use
Discover more medicines within D01AE20

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
NG	Registered Drug Product Database	04-4598, C4-2056